Rating History for ADMA Biologics (ADMA) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/10/2026 | Ryan Deschner | New Coverage | Outperform (N/A) |
21.00 (N/A) |
8.12 (8.31) |
2.34% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/10/2026 | Ryan Deschner | New Coverage | Outperform (N/A) |
21.00 (N/A) |
8.12 (8.31) |
2.34% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||